Immunoglobulins in systemic sclerosis management. A large multicenter experience

Autor: Tandaipan, J., Guillén-Del-Castillo, A., Simeón-Aznar, C.P., Carreira, P.E., De la Puente, C., Narváez, J., Lluch, J., Rubio-Rivas, M., Alegre-Sancho, J.J., Bonilla, G., Moriano, C., Casafont-Sole, I., García-Vicuña, R., Ortiz-Santamaría, V., Riera, E., Atienza-Mateo, B., Blanco, R., Galisteo, C., Gonzalez-Martin, J.J., Pego-Reigosa, J.M., Pros, A., Heredia, S., Castellví, I.

Publikováno v: In Autoimmunity Reviews November 2023 22(11)

Mapa epidemiológico transversal de las ataxias y paraparesias espásticas hereditarias en España

Autor: Ortega Suero, G., Abenza Abildúa, M.J., Serrano Munuera, C., Rouco Axpe, I., Arpa Gutiérrez, F.J., Adarmes Gómez, A.D., Rodríguez de Rivera, F.J., Quintans Castro, B., Posada Rodríguez, I., Vadillo Bermejo, A., Domingo Santos, Á., Blanco Vicente, E., Infante Ceberio, I., Pardo Fernández, J., Costa Arpín, E., Painous Martí, C., Muñoz, J.E., Mir Rivera, P., Montón Álvarez, F., Bataller Alberola, L., Gascón Bayarri, J., Casasnovas Pons, C., Vélez Santamaría, V., López de Munain, A., Fernández-Eulate, G., Gazulla Abío, J., Sanz Gallego, I., Rojas Bartolomé, L., Ayo Martín, Ó., Segura Martín, T., González Mingot, C., Baraldés Rovira, M., Sivera Mascaró, R., Cubo Delgado, E., Echavarría Íñiguez, A., Vázquez Sánchez, F., Bártulos Iglesias, M., Casadevall Codina, M.T., Martínez Fernández, E.M., Labandeira Guerra, C., Alemany Perna, B., Carvajal Hernández, A., Fernández Moreno, C., Palacín Larroy, M., Caballol Pons, N., Ávila Rivera, A., Navacerrada Barrero, F.J., Lobato Rodríguez, R., Sobrido Gómez, M.J.

Publikováno v: In Neurología July-August 2023 38(6):379-386

Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management

Autor: Vélez-Santamaría V, Nedkova-Hristova V, Morales de la Prida M, Casasnovas C

Publikováno v: International Journal of General Medicine, Vol Volume 15, Pp 8677-8684 (2022)

Valentina Vélez-Santamaría,1– 3 Velina Nedkova-Hristova,1 Moisés Morales de la Prida,1 Carlos Casasnovas1– 3 1Neuromuscular Unit, Neurology Department, Bellvitge University Hospital, Barcelona, Spain; 2Neurometabolic Diseases Laboratory, Bellv

Externí odkaz: https://doaj.org/article/b74a76729ff8408fa373c2ee183261ab

Safety, Tolerability, and Outcomes of Tafamidis for the Treatment of Acquired Amyloid Neuropathy in Domino Liver Transplant Recipients.

Autor: Nedkova-Hristova V; Neuromuscular Unit, Neurology Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Carrer de La Feixa Llarga, S/N, 08907, Barcelona, Spain.; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Donadeu L; Laboratory of Nephrology and Transplantation, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain., Baliellas C; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Liver Transplantation Unit, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., González-Costello J; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Advanced Heart Failure and Transplantation Unit, Cardiology Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Lladó L; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Liver Transplantation Unit, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., González-Vilatarsana E; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Liver Transplantation Unit, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Vélez-Santamaría V; Neuromuscular Unit, Neurology Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Carrer de La Feixa Llarga, S/N, 08907, Barcelona, Spain.; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Neurometabolic Diseases Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., de la Prida MM; Neuromuscular Unit, Neurology Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Carrer de La Feixa Llarga, S/N, 08907, Barcelona, Spain.; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Bestard O; Laboratory of Nephrology and Transplantation, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.; Kidney Transplant Unit, Nephrology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Casasnovas C; Neuromuscular Unit, Neurology Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Carrer de La Feixa Llarga, S/N, 08907, Barcelona, Spain. carloscasasnovas@bellvitgehospital.cat.; Multidisciplinary Unit of Familiar Amyloidosis, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. carloscasasnovas@bellvitgehospital.cat.; Neurometabolic Diseases Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. carloscasasnovas@bellvitgehospital.cat.; Biomedical Research Network Center in Rare Diseases (CIBERER), Madrid, Spain. carloscasasnovas@bellvitgehospital.cat.

Publikováno v: Neurology and therapy [Neurol Ther] 2024 Aug; Vol. 13 (4), pp. 1069-1080. Date of Electronic Publication: 2024 May 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.